Literature DB >> 9605447

Aspects of food and fluid intake during labour. Policies of midwives and obstetricians in The Netherlands.

H C Scheepers1, G G Essed, F Brouns.   

Abstract

OBJECTIVE: This study outlines the current policies on food and fluid intake during labour in The Netherlands and discusses the pro's and con's of food-restriction. STUDY
DESIGN: 50 midwives and 30 obstetricians were asked about their actual policy on food and fluid-intake during labour.
RESULTS: A restrictive policy during normal labour is followed by 20% of the midwives and 14% of the obstetricians. About 75% leaves the decision on food and fluid-intake to the women themselves.
CONCLUSIONS: Despite the non-restrictive policy in The Netherlands, the mortality due to the Mendelson-syndrome is not higher than in countries where a restrictive policy is followed. During normal labour there are no conclusive reasons for food or fluid-restriction. From a metabolic point of view it is hypothesized that the intake of energy-rich substrates may have a positive influence on labour progression. Further study on the subject seems indicated.

Entities:  

Mesh:

Year:  1998        PMID: 9605447     DOI: 10.1016/s0301-2115(98)00007-4

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  4 in total

1.  Eat, drink, and be labouring?

Authors:  Jennifer A Beggs; M Colleen Stainton
Journal:  J Perinat Educ       Date:  2002

Review 2.  American College of Nurse-Midwives Clinical Bulletin Number 18: Induction of Labor.

Authors:  Nicole Smith Carlson; Alexis Dunn Amore; Jessica Ann Ellis; Katie Page; Robyn Schafer
Journal:  J Midwifery Womens Health       Date:  2022-01       Impact factor: 2.891

3.  Effect of food intake during labour on obstetric outcome: randomised controlled trial.

Authors:  Geraldine O'Sullivan; Bing Liu; Darren Hart; Paul Seed; Andrew Shennan
Journal:  BMJ       Date:  2009-03-24

4.  Effect of oral carbohydrate intake on labor progress: randomized controlled trial.

Authors:  R Rahmani; Z Khakbazan; P Yavari; M Granmayeh; L Yavari
Journal:  Iran J Public Health       Date:  2012-11-01       Impact factor: 1.429

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.